scholarly journals European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O

2010 ◽  
Vol 65 (10) ◽  
pp. 2260-2262 ◽  
Author(s):  
Benoît Doublet ◽  
Laurent Poirel ◽  
Karine Praud ◽  
Patrice Nordmann ◽  
Axel Cloeckaert
2015 ◽  
Vol 59 (10) ◽  
pp. 6601-6604 ◽  
Author(s):  
Shangshang Qin ◽  
Hui Qi ◽  
Qijing Zhang ◽  
Di Zhao ◽  
Zhen-Zhen Liu ◽  
...  

ABSTRACTAcquisition ofblaNDM-1in bacterial species, such asProteus mirabilisthat is intrinsically resistant to tetracycline, tigecycline and colistin, will make clinical treatment extremely difficult. Here, we characterized an NDM-1-producing clinical isolate ofP. mirabilis(PM58) that displayed an extensively drug-resistant (XDR) phenotype, susceptible only to aztreonam. Molecular analysis revealed that PM58 harbored both a conjugative NDM-1 plasmid and a novelSalmonellagenomic island 1 variant on chromosome.


2022 ◽  
Vol 12 ◽  
Author(s):  
Lang Yang ◽  
Hong He ◽  
Qichao Chen ◽  
Kaiying Wang ◽  
Yanfeng Lin ◽  
...  

NDM-1-producing multidrug-resistant Proteus mirabilis brings formidable clinical challenges. We report a nosocomial outbreak of carbapenem-resistant P. mirabilis in China. Six P. mirabilis strains collected in the same ward showed close phylogenetic relatedness, indicating clonal expansion. Illumina and MinION sequencing revealed that three isolates harbored a novel Salmonella genomic island 1 carrying a blaNDM–1 gene (SGI1-1NDM), while three other isolates showed elevated carbapenem resistance and carried a similar SGI1 but with two blaNDM–1 gene copies (SGI1-2NDM). Four new single nucleotide mutations were present in the genomes of the two-blaNDM–1-harboring isolates, indicating later emergence of the SGI1-2NDM structure. Passage experiments indicated that both SGI variants were stably persistent in this clone without blaNDM–1 copy number changes. This study characterizes two novel blaNDM–1-harboring SGI1 variants in P. mirabilis and provides a new insight into resistance gene copy number variation in bacteria.


Author(s):  
Marion Lecuru ◽  
Marie-Hélène Nicolas-Chanoine ◽  
Sébastien Tanaka ◽  
Philippe Montravers ◽  
Laurence Armand-Lefevre ◽  
...  

2001 ◽  
Vol 45 (12) ◽  
pp. 3591-3594 ◽  
Author(s):  
Catherine Neuwirth ◽  
Stephanie Madec ◽  
Eliane Siebor ◽  
Andre Pechinot ◽  
Jean-Marie Duez ◽  
...  

ABSTRACT TEM-89 (CMT-3) is the first complex mutant β-lactamase produced by a clinical strain of Proteus mirabilis (strain Pm 631). This new enzyme, which has a pI of 6.28, is derived from TEM-3 and has a single amino acid substitution also encountered in TEM-59 (inhibitor-resistant TEM β-lactamase IRT-17): Ser-130 to Gly. TEM-89 hydrolyzed penicillins to the same extent that TEM-3 did but lost almost all hydrolytic activity for cephalosporins and, like TEM-59, was highly resistant to inhibitors.


2009 ◽  
Vol 53 (12) ◽  
pp. 5294-5296 ◽  
Author(s):  
Piklu Roy Chowdhury ◽  
John Merlino ◽  
Maurizio Labbate ◽  
Elaine Y.-L. Cheong ◽  
Thomas Gottlieb ◽  
...  

ABSTRACT A 25,441-bp transposon was recovered from a Pseudomonas aeruginosa clinical isolate. While the transposition module was >99% identical to sequence of Tn1403, the element had been subject to rearrangements, with two In70.2-like class 1 integrons inserted into it in an unusual “tail-to-tail” configuration. One cassette array was the same as that in In70.2; however, the second was different, generating a transposon that collectively includes six resistance cassettes.


Sign in / Sign up

Export Citation Format

Share Document